Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

NCT05363670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: ARS-1
DRUG: Albuterol MDI
DRUG: Placebo

Sponsor

ARS Pharmaceuticals, Inc.